Is JFL Life Sciences Ltd debt-free?

Yes, JFL Life Sciences Ltd is debt-free with a debt-to-equity ratio of 0.27.

Home

JFL Life Sciences Ltd

JFL Life Sciences Ltd Financials

JFL Life Sciences Ltd Financial Statement

JFL Life Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	11.59	11.73	21.25
Operating Expense	9.65	10.36	19.90
Net Profit	0.75	0.08	0.74
Net Profit Margin	6.47	0.68	3.48
Earning Per Share	0.23	0.03	0.22
EBIDTA	1.48	0.96	1.34
Effective Tax Rate	11.86	13.77	17.78

Particulars	Jun 2025
Revenue	11.59
Operating Expense	9.65
Net Profit	0.75
Net Profit Margin	6.47
Earning Per Share	0.23
EBIDTA	1.48
Effective Tax Rate	11.86

JFL Life Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	82.04	46.55	42.83
Operating Expenses Annual	73.84	41.97	38.90
Operating Profit Annual	8.21	5.10	5.57
Interest Annual	1.08	0.86	1.42
Depreciation	0.99	0.44	0.43
Net Profit Annual	4.16	3.30	2.81
Tax Annual	1.98	0.49	0.91

Particulars	Mar 2025
Total Revenue Annual	82.04
Operating Expenses Annual	73.84
Operating Profit Annual	8.21
Interest Annual	1.08
Depreciation	0.99
Net Profit Annual	4.16
Tax Annual	1.98

JFL Life Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	0.03	0.06	0.19
Cash Flow from Operations	-3.53	8.41	-9.07
Cash Flow from Investing	-0.01	-6.09	0.87
Cash Flow from Financing	3.54	-2.35	8.07
Cash Flow at the End	0.03	0.03	0.06

Particulars	Mar 2025
Cash Flow at the Beginning	0.03
Cash Flow from Operations	-3.53
Cash Flow from Investing	-0.01
Cash Flow from Financing	3.54
Cash Flow at the End	0.03

JFL Life Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	10.01	10.96	12.98
PBIT Margin (%)	8.80	10.01	11.98
PBT Margin (%)	0.65	-1.61	3.53
Net PROFIT Margin (%)	5.07	7.09	6.56
Return On Networth / Equity (%)	11.09	9.73	12.90
Return On Networth /Employed (%)	15.77	11.49	15.42
Return On Assets (%)	9.08	8.15	8.40
Total Debt / Equity (X)	0.22	0.19	0.53
Asset Turnover Ratio (%)	1.79	1.15	1.28

Particulars	Mar 2025
PBDIT Margin (%)	10.01
PBIT Margin (%)	8.80
PBT Margin (%)	0.65
Net PROFIT Margin (%)	5.07
Return On Networth / Equity (%)	11.09
Return On Networth /Employed (%)	15.77
Return On Assets (%)	9.08
Total Debt / Equity (X)	0.22
Asset Turnover Ratio (%)	1.79

JFL Life Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	12.24	12.47	6.80
Total Current Assets Annual	59.50	43.60	41.14
Non Current Assets Annual	12.41	13.11	7.92
Total Shareholders Funds Annual	39.46	35.58	32.27
Total Assets Annual	71.91	56.71	49.06

Particulars	Mar 2025
Fixed Assets Annual	12.24
Total Current Assets Annual	59.50
Non Current Assets Annual	12.41
Total Shareholders Funds Annual	39.46
Total Assets Annual	71.91

JFL Life Sciences Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on JFL Life Sciences Ltd Financials

As of Oct 30, 2025, JFL Life Sciences Ltd has a market capitalization of 57.58 Cr. Value Research classifies it as a Micro-Cap company.

Yes, JFL Life Sciences Ltd is with a debt-to-equity ratio of 0.27.

In FY 2024 , JFL Life Sciences Ltd recorded a total revenue of approximately 82.04 Cr marking a significant milestone in the company's financial performance.

JFL Life Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.3% annually, respectively..

JFL Life Sciences Ltd's current PE ratio is 13.84.

JFL Life Sciences Ltd's ROCE averaged 12.9% from the FY ending March 2023 to 2025, with a median of 13.0%. It peaked at 14.4% in March 2025, reflecting strong capital efficiency over the period..

JFL Life Sciences Ltd's latest EBIT is Rs. 7.22 Cr, surpassing the average EBIT of Rs. 5.67 Cr over the 5 years..